Cedars-Sinai Accelerator

What Cedars-Sinai Accelerator does

Cedars-Sinai Accelerator+ is a 12-month rolling venture-building program operated within the Cedars-Sinai Health System, the largest nonprofit academic medical center in the western United States. The program, founded in 2016 and rebranded as Accelerator+ in 2024, selects Seed+ and Late Seed healthcare startups (team size 4-12 full-time staff) working in medical devices, diagnostics, digital health, biotech, pharma, molecular development, and healthcare facility or back-office solutions. Selected companies receive financial investment in exchange for equity, dedicated co-working space adjacent to Cedars-Sinai Medical Center in Los Angeles, a curated curriculum covering FDA regulation, EMR integration, and insurance billing, and direct mentorship from more than 300 clinicians, executives, healthcare entrepreneurs, and investors. Program operations are run by a small named team (Managing Directors, Directors, Managers, Program Manager, Program Administrator, Growth and Strategy Lead, Program Coordinator, Administrative Assistant) under Cedars-Sinai Technology Ventures.

The core commercial mechanism is fast-track evaluation: the Accelerator+ team acts as liaison with relevant physicians, executive leadership, and administration to facilitate paid pilots linked to enterprise contracts within Cedars-Sinai and a national network of academic medical centers. Companies also receive preliminary data access within the clinical environment, targeted networking with local VCs and health systems, and follow-on investment evaluation upon successful pilot completion. Distribution is selective and application-based, with demo days as the bottom-of-funnel showcase.

The accelerator sits inside a broader Cedars-Sinai innovation platform that includes Cedars-Sinai Intellectual Property Company (CSIP), which manages 1,200+ patents, has executed 100+ licenses and launched 60+ technologies, and generated over $150 million in royalty income over five years; Coronet Ventures, a joint venture operating in Singapore and the Netherlands; and a Global Alliances network of 70+ strategic partners across 10 countries. Notable portfolio outcomes include Prometheus Biosciences (acquired by Merck for $10.8 billion in 2023), Santarus, Gemelli Biotech, Gravidas Diagnostics, Evida Biosciences, and Caredose. The accelerator does not operate as a standalone for-profit entity; its economics are tied to equity returns on portfolio companies and institutional mission funding from the parent nonprofit rather than recurring program fees.

Name

Cedars-Sinai Accelerator

Legal name

Cedars-Sinai

Website

https://csaccelerator.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Cedars-Sinai Accelerator+ is a 12-month, application-based venture-building program run within the Cedars-Sinai Health System for Seed+ and Late Seed healthcare startups. It provides equity investment, mentorship from 300+ clinicians and executives, and fast-track clinical validation within Cedars-Sinai and a national academic medical center network.

Ownership category

akta.pro rank

Product category

Healthcare Accelerator / Venture Development Services

NAICS

Other Scientific and Technical Consulting Services (54169), Portfolio Management and Investment Advice (523940)

SIC

Services-Management Consulting Services (8742), Investment Advice (6282)

akta.pro primary industry

Corporate Accelerators & Startup Programs (FSANAHAD)

akta.pro secondary industries

Health & Biomedical Research Universities (Academic Medical Center–Affiliated) (EDAHABAC), Accelerators & Incubators (Investor-Operated) (FSANAAAM)

Keywords

• Healthcare accelerator program
• Venture building platform
• Clinical validation services
• Medical technology investment
• Healthcare startup support

Headquarters

HQ city

Los Angeles

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Accelerator Investment: The program provides financial investment to selected companies in exchange for equity. Funding is combined with mentorship, access to Cedars-Sinai, and overall support. Companies also receive follow-on investment evaluation upon successful pilot completion.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Cedars-Sinai Accelerator+ runs a 12-month rolling accelerator program for Seed+ and Late Seed healthcare companies, providing capital investment in exchange for equity, mentorship from 300+ clinicians and executives, and guaranteed fast-track evaluation within the Cedars-Sinai Health System. The program combines hands-on portfolio support, a curated curriculum covering FDA regulation, EMR integration, and insurance billing, dedicated co-working space in Los Angeles, and access to a national network of academic medical centers for paid pilots and commercialization.

Product overview

Cedars-Sinai Accelerator+ is a single unified accelerator program designed to help early-stage healthcare startups (Seed+ and Late Seed) advance toward commercialization. The program provides a comprehensive venture-building platform that combines financial investment, hands-on mentorship from over 300 clinicians and executives, access to Cedars-Sinai's clinical environment, guaranteed fast-track evaluation for product development, co-working space, a curated curriculum covering FDA regulation, EMR integration, and insurance billing, and targeted networking with local VCs and health systems. The 12-month rolling program delivers real-world validation, streamlines clinical integration, and provides strategic guidance to scale innovation and improve patient outcomes.

Differentiator

Problem solved

Functional benefit

Brands

• Accelerator+: The current iteration of the accelerator program, operating as a comprehensive venture-building platform for Seed+ and Late Seed healthcare companies.

Products and services

• Cedars-Sinai Accelerator+ Program A 12-month rolling accelerator program for Seed+ and Late Seed healthcare companies that provides capital investment in exchange for equity, clinical and market expertise, mentorship from 300+ clinicians and executives, guaranteed fast-track evaluation, and access to Cedars-Sinai Health System for product development and commercialization. Includes dedicated co-working space in Los Angeles, a curated curriculum covering FDA regulation, EMR integration, and insurance billing, and targeted networking with local VCs and a national network of academic medical centers.

Named customers7 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• Academic Medical Centers NetworkcoreStrategic or Co-development PartnerNational network of academic medical centers looking to implement new solutions in their institutions. Provides real-world validation opportunities for accelerator companies through pilot programs and clinical integration.
• 70+ Strategic Partners Across 10 CountriescoreStrategic or Co-development PartnerGlobal Alliances initiative developed a network of over 70 strategic partners across 10 countries, supporting international expansion and partnership opportunities for accelerator portfolio companies.

Scale indicators10 records

Recent moves1 record

Expansion highlights5 records

Direct peers

• Children's National Innovation Catalyst: Innovation program at Children's National Hospital that supports pediatric and broader health-tech startups through clinical validation and pediatric care access. Directly comparable as a hospital-affiliated innovation platform offering clinical immersion and pilot pathways to early-stage healthcare startups.
• Plug and Play Health: Plug and Play's health vertical runs accelerator batches and corporate innovation programs connecting health-tech startups with health system and payer partners. Directly comparable as a corporate-partner-driven accelerator serving healthcare startups with enterprise pilot pathways.
• JLABS by Johnson & Johnson: Johnson & Johnson's no-strings-attached incubator network providing lab space, mentorship, and resources to early-stage biotech, pharma, and digital health startups. Directly comparable as a corporate-affiliated healthcare innovation platform offering residency-based support and enterprise partnership pathways.
• Mayo Clinic Platform: Mayo Clinic's healthcare innovation platform offering clinical validation, data access, and accelerator programming for health-tech startups. Directly comparable as a major nonprofit academic medical center running a portfolio-style health venture program with enterprise distribution.
• StartX Med: Stanford-affiliated startup accelerator with a dedicated medical track that supports healthcare founders through mentorship and Stanford ecosystem access. Directly comparable as a university-affiliated accelerator with a healthcare vertical and similar founder-stage focus.
• Mass General Brigham Innovation: Innovation and venture arm of Mass General Brigham that supports health-tech startups with clinical validation, pilot programs, and partnership access. Directly comparable as an East Coast academic medical center innovation platform competing for similar Seed+ healthcare startups.
• Stanford Biodesign: Stanford University-affiliated health technology innovation program that trains fellows and supports medtech startups through clinical immersion and mentorship. Directly comparable as a university-affiliated healthcare accelerator with strong clinical integration focus.
• MATTER: Chicago-based healthcare innovation hub that supports startups through mentorship, corporate partnerships, and pilot programs with health systems. Directly comparable as a healthcare-focused accelerator with strong hospital system partnerships and similar Seed-stage focus.
• Techstars Healthcare: Techstars' healthcare-focused accelerator programs that provide funding, mentorship, and enterprise access to early-stage health startups. Directly comparable as a branded accelerator program targeting Seed-stage healthcare founders with similar equity-for-services model.
• UCSF Rosenman Institute: UCSF-affiliated healthcare innovation platform that supports early-stage health startups through mentorship, clinical validation, and ecosystem access. Directly comparable as an academic medical center-affiliated accelerator targeting similar Seed+ digital health and biotech founders.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/user/zealouswebtech
• Facebookfacebook.com/csaccelerator
• LinkedInlinkedin.com/company/zealousweb
• Instagraminstagram.com/zealouswebtechnologies
• Xx.com/CSaccelerator

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments99 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cedars-Sinai Accelerator